Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Pharmacologically Antagonizing the CXCR4-CXCL12 Chemokine Pathway with AMD3100 Inhibits Sunlight-Induced Skin Cancer — Seri N.E. Sarchio (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Pharmacologically Antagonizing the CXCR4-CXCL12 Chemokine Pathway with AMD3100 Inhibits Sunlight-Induced Skin Cancer
Shared by
Richard A Scolyer
Pharmacologically Antagonizing the CXCR4-CXCL12 Chemokine Pathway with AMD3100 Inhibits Sunlight-Induced Skin Cancer
Article
2013
en
Authors
+4 more
SS
Seri N.E. Sarchio
Richard A Scolyer
CB
Clare Beaugie
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
The CXCR4 Antagonist AMD3100 Efficiently Inhibits Cell-Surface-Expressed Human Immunodeficiency Virus Type 1 Envelope-Induced Apoptosis
Julià Blanco
,
Jordi Barretina
,
Geoffrey Henson
,
Gary Bridger
,
De Clercq Erik
,
Bonaventura Clotet
,
José A. Esté
Article
2001
AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice
Patrick Matthys
,
Sigrid Hatse
,
Kurt Vermeire
,
Anja Wuyts
,
Gary Bridger
,
Geoffrey Henson
,
De Clercq Erik
,
Alfons Billiau
,
Dominique Schols
Article
2003
The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level
Katrien Princen
,
Sigrid Hatse
,
Kurt Vermeire
,
Gary Bridger
,
Renato T. Skerlj
,
De Clercq Erik
,
Dominique Schols
Article
2003
The Antiviral Activity of the CXCR4 Antagonist AMD3100 Is Independent of the Cytokine-Induced CXCR4/HIV Coreceptor Expression Level
Katrien Princen
,
Sigrid Hatse
,
Kurt Vermeire
,
Gary Bridger
,
Renato T. Skerlj
,
De Clercq Erik
,
Dominique Schols
Article
2001
Mutation of Asp171 and Asp262 of the Chemokine Receptor CXCR4 Impairs Its Coreceptor Function for Human Immunodeficiency Virus-1 Entry and Abrogates the Antagonistic Activity of AMD3100
Sigrid Hatse
,
Katrien Princen
,
Lars‐Ole Gerlach
,
Gary Bridger
,
Geoffrey Henson
,
De Clercq Erik
,
Thue W. Schwartz
,
Dominique Schols
Discussion(0)
No comments yet. Be the first to comment.